Fiocruz, Institut Pasteur and Sanofi sign vaccine alliance

During Brazil President Luiz Inácio Lula da Silva's mission to France, the research institute Fiocruz, which was part of the official Presidential entourage, signed a new alliance with the Institut Pasteur and French pharma major Sanofi (Euronext: SAN) to promote innovative solutions and advances in vaccine technology.

The agreement that Fiocruz signed with Sanofi and the Institut Pasteur combined research and production, demonstrating the dynamism and capacity of the Health Economic and Industrial Complex [Ceis].

For the president of Fiocruz, Mario Moreira, the new alliance reaffirms the foundation's historic commitment to universal access to vaccination, based on strengthening the National Immunization Program (PNI) and innovation in the development of health supplies.